New gene and blood-test approaches for muscular dystrophy
MDSRC for Next Directions in Muscular Dystrophy Research
['FUNDING_OTHER'] · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · NIH-11169966
This center is developing improved gene therapies and blood-based tests to help people with muscular dystrophy, including limb-girdle and dystrophin-related forms.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH INST NATIONWIDE CHILDREN'S HOSP (nih funded) |
| Locations | 1 site (COLUMBUS, UNITED STATES) |
| Trial ID | NIH-11169966 on ClinicalTrials.gov |
What this research studies
Researchers at Nationwide Children’s are building and sharing tools to move lab discoveries toward treatments for muscular dystrophy patients. One project uses a novel bicistronic AAV vector designed to both prevent muscle damage and add new muscle function for people with LGMD2I. Another project is reprogramming U7 small nuclear RNAs to restore working dystrophin protein in dystrophin-deficient conditions. A third project looks for circulating blood markers and ways to boost gene delivery and lower immune reactions to AAV therapies.
Who could benefit from this research
Good fit: Ideal candidates would include people with Limb-Girdle Muscular Dystrophy type 2I and patients with dystrophin-deficient muscular dystrophies (such as Duchenne) who are eligible for gene-therapy approaches or biospecimen donation.
Not a fit: People whose muscle weakness is not caused by the targeted genetic defects, or those with advanced organ failure or other contraindications to gene therapy, may not benefit from these projects.
Why it matters
Potential benefit: If successful, this work could produce safer, more effective gene therapies and blood tests that track disease and treatment response in muscular dystrophy patients.
How similar studies have performed: Related AAV-based and microdystrophin gene therapies have shown early promise in patients but remain experimental and face challenges like immune responses, so these projects build on prior progress while testing new strategies.
Where this research is happening
COLUMBUS, UNITED STATES
- RESEARCH INST NATIONWIDE CHILDREN'S HOSP — COLUMBUS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FLANIGAN, KEVIN M — RESEARCH INST NATIONWIDE CHILDREN'S HOSP
- Study coordinator: FLANIGAN, KEVIN M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.